| scholarly article | Q13442814 |
| P50 | author | Kelli L. Boyd | Q116621330 |
| Monica Cardone | Q130293214 | ||
| P2093 | author name string | Jonas A Nilsson | |
| John L Cleveland | |||
| Ugur Ozbek | |||
| Ayten Kandilci | |||
| Gerard C Grosveld | |||
| Cintia Carella | |||
| Jennifer A Brennan | |||
| Sema Sirma | |||
| P2860 | cites work | TEL is a sequence-specific transcriptional repressor | Q22010632 |
| Identification and characterization of a new human ETS-family transcription factor, TEL2, that is expressed in hematopoietic tissues and can associate with TEL1/ETV6 | Q22254171 | ||
| Tel-2 is a novel transcriptional repressor related to the Ets factor Tel/ETV-6 | Q24290595 | ||
| Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL | Q28592571 | ||
| Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis | Q28593886 | ||
| Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization | Q29614701 | ||
| Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF | Q29619663 | ||
| The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. | Q33889383 | ||
| Characterization of a novel ETS gene, TELB, encoding a protein structurally and functionally related to TEL. | Q33921480 | ||
| Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages | Q33933240 | ||
| Proteins of the ETS family with transcriptional repressor activity | Q34139422 | ||
| Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma | Q34160782 | ||
| Molecular biology of the Ets family of transcription factors | Q34174026 | ||
| Transcriptional regulation of the bcl-x gene encoding the anti-apoptotic Bcl-xL protein by Ets, Rel/NFkappaB, STAT and AP1 transcription factor families | Q34238502 | ||
| Apoptosis and chemoresistance in transgenic cancer models | Q34563810 | ||
| Cell cycle deregulation in B-cell lymphomas. | Q34977269 | ||
| The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow | Q35206654 | ||
| Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis | Q35208288 | ||
| INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. | Q35208402 | ||
| bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. | Q36366215 | ||
| Distinct roles for E2F proteins in cell growth control and apoptosis | Q36653915 | ||
| Expression of the c-myc oncogene under control of an immunoglobulin enhancer in E mu-myc transgenic mice | Q36838691 | ||
| High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. | Q38288856 | ||
| Pi 1 binding sites are negative regulators of bcl-2 expression in pre-B cells | Q40016702 | ||
| Tel, a frequent target of leukemic translocations, induces cellular aggregation and influences expression of extracellular matrix components. | Q40452513 | ||
| A breakpoint map of recurrent chromosomal rearrangements in human neoplasia | Q40899125 | ||
| The TEL gene contributes to the pathogenesis of myeloid and lymphoid leukemias by diverse molecular genetic mechanisms. | Q41431729 | ||
| Establishment of a reproducible culture technique for the selective growth of B-cell progenitors | Q41647602 | ||
| Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. | Q41714456 | ||
| TEL, a putative tumor suppressor, induces apoptosis and represses transcription of Bcl-XL. | Q42796261 | ||
| The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A. | Q42809374 | ||
| TEL2, an ETS factor expressed in human leukemia, regulates monocytic differentiation of U937 Cells and blocks the inhibitory effect of TEL1 on ras-induced cellular transformation | Q42825938 | ||
| Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. | Q43459895 | ||
| The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia | Q47335313 | ||
| Ets transcription factors and human disease | Q48027304 | ||
| Activation of a translocated human c-myc gene by an enhancer in the immunoglobulin heavy-chain locus | Q48393487 | ||
| Chromosomal translocations in human cancer. | Q52512616 | ||
| Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. | Q52526599 | ||
| Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss. | Q53380068 | ||
| High resolution mapping of chromosome 6 deletions in cervical cancer. | Q53422516 | ||
| DNA damage responses and chemosensitivity in the E mu-myc mouse lymphoma model. | Q53929522 | ||
| p14ARF links the tumour suppressors RB and p53. | Q55067966 | ||
| The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic mice | Q57338720 | ||
| The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice | Q57338722 | ||
| Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma | Q70449918 | ||
| Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss | Q72245131 | ||
| Changes in DNA copy number in primary gastric carcinomas by comparative genomic hybridization | Q77554585 | ||
| Widespread chromosomal abnormalities in high-grade ductal carcinoma in situ of the breast. Comparative genomic hybridization study of pure high-grade DCIS | Q77976509 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell biology | Q7141 |
| P304 | page(s) | 2395-405 | |
| P577 | publication date | 2005-03-01 | |
| P1433 | published in | Molecular and Cellular Biology | Q3319478 |
| P1476 | title | The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis | |
| P478 | volume | 25 |
| Q36561755 | Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia |
| Q38940069 | Cooperative interactions between p53 and NFκB enhance cell plasticity. |
| Q41224538 | Downregulation of Friend Leukemia Virus Integration 1 as a Feedback Mechanism That Restrains Lipopolysaccharide Induction of Matrix Metalloproteases and Interleukin-10 in Human Macrophages |
| Q58745901 | ETV7 is an essential component of a rapamycin-insensitive mTOR complex in cancer |
| Q58416369 | ETV7-Mediated DNAJC15 Repression Leads to Doxorubicin Resistance in Breast Cancer Cells |
| Q93382524 | Establishment of a transgenic mouse to model ETV7 expressing human tumors |
| Q92106885 | Global Transcriptome Profiling of Multiple Porcine Organs Reveals Toxoplasma gondii-Induced Transcriptional Landscapes |
| Q41903687 | Identifying new targets in leukemogenesis using computational approaches |
| Q35729943 | Ink4a and Arf are crucial factors in the determination of the cell of origin and the therapeutic sensitivity of Myc-induced mouse lymphoid tumor. |
| Q34631634 | MN1 overexpression is an important step in the development of inv(16) AML. |
| Q24669642 | MN1-TEL myeloid oncoprotein expressed in multipotent progenitors perturbs both myeloid and lymphoid growth and causes T-lymphoid tumors in mice |
| Q53344487 | MN1-TEL, the product of the t(12;22) in human myeloid leukemia, immortalizes murine myeloid cells and causes myeloid malignancy in mice. |
| Q34692292 | Mapping of MN1 sequences necessary for myeloid transformation |
| Q34972364 | Myc roles in hematopoiesis and leukemia |
| Q39728196 | PRL-2 increases Epo and IL-3 responses in hematopoietic cells |
| Q36800430 | Patterns of regulatory activity across diverse human cell types predict tissue identity, transcription factor binding, and long-range interactions |
| Q37620148 | Polycomb group proteins: navigators of lineage pathways led astray in cancer |
| Q24647331 | Reintroduction of CEBPA in MN1-overexpressing hematopoietic cells prevents their hyperproliferation and restores myeloid differentiation |
| Q35915972 | SET-CAN, the product of the t(9;9) in acute undifferentiated leukemia, causes expansion of early hematopoietic progenitors and hyperproliferation of stomach mucosa in transgenic mice |
| Q36557268 | TEL2 suppresses metastasis by down-regulating SERPINE1 in nasopharyngeal carcinoma |
| Q35850023 | The ETS factor TEL2 is a hematopoietic oncoprotein |
| Q34555986 | The ETS family of oncogenic transcription factors in solid tumours. |
| Q41929611 | Zebrafish ETV7 regulates red blood cell development through the cholesterol synthesis pathway |
Search more.